Ramy Farid

Filings by Ramy Farid span 3 companies, the busiest being Schrodinger, Inc., Vir Biotechnology, Inc. and Structure Therapeutics Inc. The record holds 19 filings, for trades running from 12 August 2020 to 27 May 2026.

Sales make up the whole of the open-market record (11 sales, €8.5M). Outside the open market, there are 5 share grants and 2 option exercises. Since January 2026: no purchases and 1 sale on the market.

The latest filing, published on 28 May 2026, reports a share grant in Vir Biotechnology, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.